Windtree Therapeutics, Inc. (WINT) Dividend History

Company News

• Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

  Evofem Biosciences has entered into an agreement with Windtree Therapeutics to reduce the manufacturing cost of its contraceptive product PHEXXI by 55-60%. This will allow Evofem to expand PHEXXI's global availability, particularly in price-sensitive markets.

  Benzinga
• US Stocks Likely To Open Lower After 3-Day Advance: Market Is Looking 'More Balanced' And Gone From 'Above-Trend To On-Trend,' Says Expert

  US stock futures are trading lower after a three-day advance, as investors react cautiously to President Trump's mixed tariff signals. The market is looking more balanced, having moved from 'above-trend to on-trend', according to an expert.

  Benzinga

  Featured Companies: CISO GME HUMA QQQ SPY THTX
• Windtree Announces the Addition of Leanne Kelly to Its Board of Directors

  Windtree Therapeutics, a biotechnology company, announced the appointment of Leanne Kelly to its board of directors. Ms. Kelly has significant public company executive experience and will serve as an independent director and chair of the audit committee.

  GlobeNewswire Inc.

  Featured Companies: GRI
• Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

  Windtree Therapeutics has filed a new patent application for istaroxime, a drug candidate that has shown potential in reducing the risk of acute myocardial arrhythmia in animal studies and clinical trials for acute heart failure and cardiogenic shock.

  GlobeNewswire Inc.
• Eagle Point Income reports NAV per share and quarterly earnings By Investing.com - Investing.com

  Windtree Therapeutics, a biotechnology firm, has secured $200,000 in private notes, including senior secured and unsecured promissory notes. The company has also seen recent developments such as a reverse stock split and securing new financing options.

  Investing.com